EXPANDED ACCESS PROTOCOL (EAP) FOR SUBJECTS RECEIVING IDECABTAGENE VICLEUCEL THAT IS NONCONFORMING FOR COMMERCIAL RELEASE
Details
Age
Adult
Locations
University of Colorado Hospital
Principal Investigator
Jonathan Gutman
Study ID
Protocol Number: 21-5082
More information available at ClinicalTrials.gov: NCT04771078
Categories
Is this Study for You?
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers